Virtual Investor Co.

An online platform that offers public and private companies, across multiple industries the ability to stay active and engaged with the investment community.

[Virtual Investor Co. @InvestorVirtual]

Dr. Toufic Kachaamy, Chief of Medicine at City of Hope Phoenix, joins a #WhatThisMeans segment to discuss the clinical significance of $AMIX’s data presented at the SSO Annual Meeting and its selection for a podium presentation.

🔗: https://t.co/Pqr6PuEUpL
#MedTech

[Virtual Investor Co. @InvestorVirtual]

In a #WhatThisMeans segment, Tom Equels, Dr. Charles Lapp and Dr. Christopher Nicodemus, examine current Ebola outbreak concerns, the unmet need surrounding the Bundibugyo strain, and Ampligen’s previously published antiviral research.

🔗: https://t.co/ggmYEojLQQ
$AIM #Ebola

[Virtual Investor Co. @InvestorVirtual]

In a #WhatThisMeans segment, Walter Klemp, CEO of $MBRX, discusses the enrollment of the 45th subject in Moleculin’s pivotal Phase 2B/3 MIRACLE trial evaluating AnnAraC for relapsed or refractory AML.

🔗Watch here: https://t.co/I6eaupFPUq

[Virtual Investor Co. @InvestorVirtual]

📅 Mark Your Calendar

enVVeno Medical will take part in a #VirtualInvestor Closing Bell segment on June 9 at 4 PM ET. Tune in to hear key updates from CEO Robert Berman.

Register Here: https://t.co/qIjar17vVo

$NVNO #VenousDisease #DeepVenousInsufficiency #CVI #CVD

[Virtual Investor Co. @InvestorVirtual]

In a #VirtualInvestor “What This Means” segment, @akaritx CEO Abizer Gaslightwala discusses the Company’s first ASCO abstract acceptance and preclinical KRAS synergy data supporting its differentiated ADC platform.

Watch here: https://t.co/V2zrm2bNct

$AKTX #ASCO #Oncology

[Virtual Investor Co. @InvestorVirtual]

In a #VirtualInvestor #KOLConnect segment, Dr. Elena Ratner discusses the unmet need in ovarian cancer, immunologically “cold” tumors, and Ernexa’s differentiated off-the-shelf cell therapy approach.

🔗https://t.co/UY4fw4Z4hu
$ERNA @ernexatx

[Virtual Investor Co. @InvestorVirtual]

In a #VirtualInvestor #CEOConnect segment, Rami Levin highlights the Company’s recent strategic transformation progress, including its $22.5 million financing and pipeline development strategy focused on long-term shareholder value creation.

🔗: https://t.co/cTPaYafuSe

$CNSP

[Virtual Investor Co. @InvestorVirtual]

@AimImmuno In a #KOLConnect segment, Professor Dr. Casper H.J. van Eijck joins CEO Tom Equels to discuss Ampligen’s potential in late-stage pancreatic cancer, highlighting its mechanism of action, clinical data, development strategy, and key regulatory milestones.

[Virtual Investor Co. @InvestorVirtual]

In a #KOLConnect segment, Professor Dr. Casper H.J. van Eijck joins CEO Tom Equels to discuss Ampligen’s potential in late-stage pancreatic cancer, highlighting its mechanism of action, clinical data, development strategy, and key regulatory milestones.

https://t.co/w3RJJ78tqX

[Virtual Investor Co. @InvestorVirtual]

⏰ We will be Live Soon!

#ERNA is about to begin its #VirtualInvestor Closing Bell event. Tune in for the latest updates and take part in the live Q&A.

Join here 👇
https://t.co/bCvN1jowe7

#CancerResearch #DeliveringHope @ernexatx

[Virtual Investor Co. @InvestorVirtual]

🔔 Live Today at 4 PM ET!

Catch @ernexatx live in their #VirtualInvestor Closing Bell segment for the latest corporate updates, key progress highlights, and a look at upcoming initiatives.

Watch live here: https://t.co/bCvN1jowe7

$ERNA #CancerResearch #DeliveringHope

[Virtual Investor Co. @InvestorVirtual]

⏰ Happening Tomorrow at 4 PM ET

Join CEO Sanjeev Luther live as he discusses the latest updates from $ERNA during a #VirtualInvestor Closing Bell session. Be sure to tune in!

Don't miss it: https://t.co/bCvN1jowe7

#CancerResearch #DeliveringHope @ernexatx

[Virtual Investor Co. @InvestorVirtual]

@enVVenoMedical joined a #WhatThisMeans segment to discuss the FDA’s first-ever IDE approval for a U.S. pivotal study evaluating a non-surgical replacement venous valve and what this could mean for the ~3 million U.S. patients suffering from DVI.

🔗: https://t.co/Mx3HIq3eJO

[Virtual Investor Co. @InvestorVirtual]

Virtual Investor KOL Connect: @ErnexaTx features CSO, Dr. Pierce, to discuss the ovarian cancer landscape, unmet need and the potential of their lead development asset to address limitations.

[Virtual Investor Co. @InvestorVirtual]

Starting Soon!

$AIM goes live at 4 PM ET in the #VirtualInvestor Closing Bell.

Tune in to hear from CEO Tom Equels and participate in the live Q&A.

Join now: https://t.co/rPsCez4GM7
#CancerResearch #PancreaticCancer #BreastCancer @aimimmuno

[Virtual Investor Co. @InvestorVirtual]

Tune in Today!

$AIM will be featured in the #VirtualInvestor Closing Bell at 4 PM ET.

Don’t miss insights from CEO Tom Equels, plus a live Q&A session.

Register here: https://t.co/rPsCez4GM7
#CancerResearch #PancreaticCancer #BreastCancer @aimimmuno

[Virtual Investor Co. @InvestorVirtual]

🔴 Starting Now!

$AREC is live in the #VirtualInvestor CEO Connect.

Hear from CEO Mark Jensen and join the live Q&A.

Join now: https://t.co/uAIioc9Mm7
#RareEarths #SupplyChain

[Virtual Investor Co. @InvestorVirtual]

Tune in Today!

$AREC will be featured in the #VirtualInvestor CEO Connect at 10 AM ET.

Hear from CEO Mark Jensen, followed by a live Q&A.

Join here: https://t.co/uAIioc9Mm7

#RareEarths #SupplyChain

[Virtual Investor Co. @InvestorVirtual]

⏰ Happening Tomorrow at 4 PM ET
$AIM is taking part in the #VirtualInvestor Closing Bell.

Hear from CEO Thomas K. Equels and get your questions answered live.

Secure your spot: https://t.co/rPsCez4GM7
#CancerResearch #PancreaticCancer #BreastCancer @aimimmuno